Infusion Care neria™
Infusion Care neria™
Infusion Care neria™ is specialised in infusion sets developed specifically for subcutaneous drug delivery, including apomorphine for Parkinson’s disease, immunoglobulins for primary immune deficiencies, deferal for thalassaemia (a rare blood disorder) and morphine for pain management. Infusion sets for these therapeutic areas are distributed under our brand name neria™.
The neria™ infusion sets can be used in different therapy areas and provide a number of features which support the use of the products for both patients and healthcare professionals:
• Simplicity - Simple and easy-to-use features such as pre-attached adhesive
• Comfort - Soft and flexible cannulae options and visual monitoring of sites
• Safety - In vitro tested especially for subcutaneous use and drug compatible1,2,3,4,5
• Efficacy - Strong double layer tubing with very low priming volumes
Clinical studies have shown that neria™ infusion sets helped minimize pain during insertion and reduced needle related traumas.6,7
1 Stability test and function test of Comfort and Contact Detach by means of the medicament APO-go. Analysis report no. 294690. January 14-April 1, 2009. Data on file. Unomedical.
2 Drug Device Stability Test Thalaset – Study Desferal (deferoxamine mesilate). July 1, 2005. Data on file. Unomedical.
3 Compatibility and stability testing of the catheter device Unomedical comfort™ with the immunoglobulin Subcuvia. IKFE 09016. April 16, 2009. Data on file. Unomedical.
4 Drug Compatibility Study of Three Infusion Devices with Morphine Sulfate, version 1.4, IKFE 10006, September 2, 2011, Data on File. Unomedical.
5 Drug Compatibility Study of Three Infusion Devices with Hydromorphone Hydrochloride, version 1.4, IKFE 10006, September 2, 2011, Data on File. Unomedical.
6. Chan G.C.F., NgD.M.W. Et al, comparison of Subcutaneous Infusion needles for Transfusion-Dependant Thalasseamia Patients by the Intrapersonal Cross-Over Assessment Model, Am.J. Hematol, 76;398-404
7. Parsons J., Infusion Line prefernces of patients prescribed apomorphine for complex Parkinson's disease. British Journal of Neuroscience Nursing. December 2009, Vol 5 No 12